Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting

Go back to Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
DYNEGY, Inc. (NASDAQ: DYN) Delayed: 17.11 -0.95 (5.26%)
Previous Close $18.06    52 Week High $22.01 
Open $18.07    52 Week Low $7.01 
Day High $18.15    P/E N/A 
Day Low $16.96    EPS $0.00 
Volume 4,849,572